Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   JEFFREY ROSEN   and   Alex Smith.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            1.133
         
        
        
     
 
    
        
        - 
            Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast Cancers. bioRxiv. 2025 May 06.
            
            
                Score: 0.242
            
         
        
        - 
            CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer. JCI Insight. 2024 Sep 17; 9(20).
            
            
                Score: 0.231
            
         
        
        - 
            CBP/P300 BRD Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in TNBC. bioRxiv. 2024 Apr 27.
            
            
                Score: 0.225
            
         
        
        - 
            Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer. J Clin Invest. 2023 12 15; 133(24).
            
            
                Score: 0.219
            
         
        
        - 
            Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer. bioRxiv. 2023 Sep 28.
            
            
                Score: 0.216